Re: Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy: Effects of Androgen-Deprivation Therapy Editorial Comment

被引:1
|
作者
Penson, David F.
机构
来源
JOURNAL OF UROLOGY | 2016年 / 196卷 / 01期
关键词
D O I
10.1016/j.juro.2016.04.029
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:104 / 105
页数:2
相关论文
共 50 条
  • [1] Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy Effects of Androgen-Deprivation Therapy
    Sun, Maxine
    Choueiri, Toni K.
    Hamnvik, Ole-Petter R.
    Preston, Mark A.
    De Velasco, Guillermo
    Jiang, Wei
    Loeb, Stacy
    Nguyen, Paul L.
    Quoc-Dien Trinh
    [J]. JAMA ONCOLOGY, 2016, 2 (04) : 500 - 507
  • [2] The adverse effects of androgen-deprivation therapy: Comparison between gonadotropin-releasing hormone agonists and orchiectomy in the SEER-Medicare population
    Sun, Maxine
    Hamnvik, Ole-Petter Riksfjord
    de Velasco, Guillermo
    Jiang, Wei
    Loeb, Stacy
    Nguyen, Paul L.
    Trinh, Quoc-Dien
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [3] Chemical vs Surgical ADT in Metastatic Prostate Cancer: A Comparison of Side Effects. Commentary on Comparison of Gonadotropin-releasing Hormone Agonists and Orchiectomy: Effects of Androgen Deprivation Therapy
    Van Asseldonk, Brandon
    Black, Peter
    Elterman, Dean S.
    [J]. UROLOGY, 2016, 93 : 3 - 4
  • [4] Effects of gonadotropin-releasing hormone agonists on leiomyomas
    Mesia, AF
    Popiolek, D
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1999, 123 (04) : 282 - 283
  • [5] Re: Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist Editorial Comment
    Taneja, Samir S.
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : 985 - 985
  • [6] Effects of gonadotropin-releasing hormone agonists on uterine leiomyomas
    Cramer, SF
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1998, 122 (12) : 1045 - 1045
  • [7] Effects of gonadotropin-releasing hormone agonists on leiomyomas - In reply
    Kalir, T
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1999, 123 (04) : 283 - 283
  • [8] Editorial Comment to Considerations for the use of gonadotropin-releasing hormone agonists and antagonists in patients with prostate cancer
    Kawahara, Takashi
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (10) : 837 - 838
  • [9] Metabolic consequences of gonadotropin-releasing hormone agonists vs orchiectomy: a randomized clinical study
    Ostergren, Peter B.
    Kistorp, Caroline
    Fode, Mikkel
    Bennedbaek, Finn N.
    Faber, Jens
    Sonksen, Jens
    [J]. BJU INTERNATIONAL, 2019, 123 (04) : 602 - 611
  • [10] Cardiovascular side effects in patients undergoing androgen deprivation therapy: superiority of gonadotropin-releasing hormone antagonists? An update
    von Amsberg, Gunhild
    Thiele, Holger
    Merseburger, Axel
    [J]. UROLOGE, 2021, 60 (11): : 1450 - 1457